Life Insurance with AFib: How Managed Cases Get Standard Rates (2026)

Atrial fibrillation has a scary name, a scarier Wikipedia page, and — here’s the part nobody tells you in the cardiologist’s waiting room — surprisingly civilized life insurance outcomes when it’s managed. Millions of Americans live with AFib on a beta blocker and a blood thinner, and carriers underwrite it every single day.

Managed AFib with a clean cardiac workup typically lands between Standard and Table 2. Occasional paroxysmal episodes with a structurally normal heart can even do better. The cases that get expensive are the ones with question marks: no workup, no treatment plan, or AFib tangled up with heart failure or valve disease. Your job — and mine — is making sure your file reads as the managed kind.

Why your TYPE of AFib drives the price

The cardiac workup underwriters want to see

The echo

An echocardiogram showing normal chambers, valves, and ejection fraction reframes everything. If yours is older than 2–3 years, a fresh one before applying often pays for itself in premium.

Stroke prevention

This surprises people: being ON a blood thinner (Eliquis, Xarelto) usually helps your file when your risk score warrants it. It shows the #1 AFib danger — stroke — is being actively managed. Untreated AFib with stroke risk factors is what makes underwriters reach for the decline stamp.

Underwriters see two eras of AFib charts. The older ones run on warfarin, with regular blood draws to keep the INR in range. The newer ones — most non-valvular AFib today — run on a DOAC: Eliquis, Xarelto, Pradaxa, Savaysa. No routine monitoring, fewer food and drug fights.

The file that raises questions is the mismatch: a stroke-risk score that says you should be anticoagulated, and no thinner in the chart, with no reason given. That does not read as low risk. It reads as an open question — and open questions are what get priced.

If you are not on a thinner because your score is genuinely low, that is a fine answer. It just has to be the chart’s answer, not a gap. One line from your cardiologist explaining the decision does more for your file than anything I can argue on your behalf.

What your CHA₂DS₂-VASc score means

Your cardiologist has a score for your stroke risk, even if nobody has said it out loud. It is called CHA₂DS₂-VASc, and it is the reason you are — or are not — on a blood thinner.

It is a point system. You collect points for heart failure, high blood pressure, diabetes, vascular disease, and being female. Being 65 to 74 is worth a point; being 75 or older is worth two. A previous stroke or TIA is worth two — the heaviest item on the list, which tells you exactly what the score is built to predict.

Under current guidelines, men at 2 or more and women at 3 or more are recommended for anticoagulation — roughly where yearly stroke risk crosses 2%. It is worth knowing your number before you apply. It is the clearest one-line summary of the thing your cardiologist and your underwriter are both trying to answer.

Episode control

How often, how long, and when was the last one? Documented rhythm control or successful rate control with no recent ER visits reads beautifully.

The company AFib keeps

Thyroid issues, sleep apnea, alcohol, and blood pressure all feed AFib. Treated triggers strengthen your story — my sleep apnea and blood pressure guides cover two of the big ones.

This is not a side note. The current guidelines put risk-factor management on the same page as rhythm drugs, not in a footnote. Untreated sleep apnea, an overactive thyroid, heavy drinking, uncontrolled blood pressure, and extra weight all keep AFib coming back.

Which cuts both ways on your application. AFib sitting next to untreated sleep apnea reads like a problem that is not finished. The same AFib next to a CPAP compliance report reads like a problem someone is managing. These are also the parts you can still change before you apply — and weight belongs on that list too.

What you’ll pay: 2026 rate ranges

Monthly ranges for a $500,000, 20-year term, male non-smoker. Women run 15–25% less.

Estimates only — not a quote. Your actual offer is set at underwriting and varies by carrier, your full file, and your health at the time you apply.

Ablation, cardioversion & the reset button

Had a successful ablation? This is the closest thing to an underwriting reset that exists for AFib. Six to twelve months post-ablation with no recurrence, carriers increasingly treat you as a dramatically improved risk — some approach normal-heart pricing after a clean year or two. Keep every follow-up EKG; they’re receipts.

One thing worth knowing before you apply: the first three months after an ablation are called the blanking period. Episodes during that window are common, expected, and do not mean the ablation failed — the heart is still settling. Your cardiologist knows that. An underwriter reading a raw chart may just see “AFib episode, March.”

That is the best argument for not applying the week after your procedure. You want the file to show the result, not the recovery. Past the blanking period, off antiarrhythmic drugs, with no sustained recurrence documented — that is a different story than “had an ablation.”

Cardioversions read as treatment events, not failures — but multiple recent ones suggest unstable rhythm and push toward waiting 6–12 stable months before applying.

The watch-and-wait diagnosis: if you were told you had “a touch of AFib” years ago and nothing since, get it documented. A single resolved episode with years of normal rhythm can underwrite remarkably close to clean — but only if the records actually say so.

What this looks like in practice

Illustrative examples — composite scenarios based on typical AFib underwriting, not actual clients.

The clean file — 58, paroxysmal. A few episodes a year, a structurally normal echo from last spring, on Eliquis because his score called for it, blood pressure controlled. Nothing dramatic in the chart — and that is the point. Nothing dramatic is what Standard looks like. His AFib was never really the question. His heart was, and the echo answered it.

The trigger nobody treated — 62, persistent. Persistent AFib, rate-controlled, no complaints — and undiagnosed sleep apnea sitting right next to it. The first read priced the pair, not the AFib. After a sleep study, three months of CPAP compliance data, and a current echo, the same heart was a materially better file. Same diagnosis. Different story.

Applied one month too early — 54, post-ablation. Ablation in January, application in February, still inside the blanking period. The chart showed exactly what a blanking period shows: episodes. He was not declined — he was told to come back. At nine months, off antiarrhythmics with no recurrence documented, the file read like a reset instead of a recovery. Same procedure, eight months of patience.

What to do next

1. Gather the cardiac paper trail: last echo, current meds, episode history, any ablation/cardioversion dates.

2. Run a quote or call me first — AFib is a condition I always shop informally before any formal application, because carrier appetite varies sharply.

3. If your workup is stale, see your cardiologist before applying. Fresh clean data beats old ambiguous data by a full rate class.

Frequently asked questions

Phillip Chin — Independent Life & Disability Insurance Broker

Phillip has helped families and professionals across the country find the right coverage since 2008. He works with 25+ A-rated carriers, charges no broker fees, and answers his own phone. More about Phillip →